SARS-CoV-2 productively infects human brain microvascular endothelial cells - Journal of Neuroinflammation

United Kingdom News News

SARS-CoV-2 productively infects human brain microvascular endothelial cells - Journal of Neuroinflammation
United Kingdom Latest News,United Kingdom Headlines
  • 📰 BioMedCentral
  • ⏱ Reading Time:
  • 71 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 32%
  • Publisher: 71%

Research published in the Journal of Neuroinflammation reports that SARS-CoV-2 infection can cause blood–brain barrier dysfunction and lead to central nervous system inflammatory responses.

-value in multiple tests. Here, only genes with logDifferentially expressed genes were compared against various databases for functional annotation. We compared the plant-specific sequences from the NCBI-nr database and the Swiss-Prot database by using basic local alignment search tool x with an e-value cut-off of 10. The best BLAST hit based on the bit score was used for subsequent functional annotation.

. Kyoto Encyclopedia of Genes and Genomes pathway annotation was performed using BLAST x against plant-specific sequences from the KEGG database. GO and KEGG enrichment analyses were performed using the hypergeometric test as implemented in the R phyper function.Reverse transcription PCR was performed with 1 μg aliquots of total RNA from each sample and was followed by complementary DNA synthesis using the HiScript II Q Select RT SuperMix for qPCR .

For SARS-CoV-2 RT-qPCR, 100 ng of RNA was used as a template for the amplification of selected genes by using TransScript® II Probe One-Step RT-qPCR SuperMix . Average values from duplicates of each gene were used to calculate the viral genomic copies. Sequences of the primers targeting the SARS-CoV-2 RdRP gene were as follows: 5′-CAATGGTTTAACAGGCACAGG-3′ and 5′-CTCAAGTGTCTGTGGATCACG-3′ . RT-qPCR was performed following the manufacturers’ instructions.

Mouse brain sections were incubated with primary TJP1 , OCLN , CLDN5 , ICAM1 , VCAM1 antibody , CD44 antibody , or SARS-COV-2 spike antibody , followed by incubation with secondary antibody conjugated with Cy3 . The same sections were then incubated with CD31 primary antibody, followed by incubation with the appropriate secondary antibody fluorescein isothiocyanate prior to final nuclear staining with DAPI. The sections were photographed and analyzed using a BX41 microscope .

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

BioMedCentral /  🏆 22. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Brain immune response to SARS-CoV-2 infectionBrain immune response to SARS-CoV-2 infectionIn a recently published article in the journal Current Opinion in Neurobiology, scientists at Washington University School of Medicine, St. Louis have described how immunological alterations associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may impact brain activities and induce acute and post-acute neurological symptoms in coronavirus disease 2019 (COVID-19) patients.
Read more »

Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of ConcernAbstractBackground. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge, and effective tracking requires rapid return of re
Read more »

Elevated cerebrospinal fluid biomarkers of neuroinflammation in NeuroCOVID patientsElevated cerebrospinal fluid biomarkers of neuroinflammation in NeuroCOVID patientsA new research paper studied several biomarkers associated with neuronal injury, neuroinflammation, and neurodegeneration in NeuroCOVID adults who experienced a CNS syndrome during acute SARS-CoV-2 infection.
Read more »

Herpesvirus and neurological manifestations in patients with severe coronavirus disease - Virology JournalHerpesvirus and neurological manifestations in patients with severe coronavirus disease - Virology JournalBackground Certain clinical manifestations of coronavirus disease (COVID-19) mimic those associated with human herpesvirus (HHV) infection. In this study, we estimated the prevalence of herpesvirus in patients with COVID-19 and determined if coinfection is associated with poorer outcomes and neurological symptoms. Methods We analyzed samples of 53 patients diagnosed with COVID-19. The samples were evaluated for the presence of alphaherpesviruses, betaherpesviruses, and gammaherpesviruses, and the viral loads were quantified using quantitative polymerase chain reaction (qPCR) method. Results Among the patients, in 79.2% had detection at least one type of herpesvirus. HHV-6 (47.2%), cytomegalovirus (43.3%), and HHV-7 (39.6%) showed the highest detection rates. Patients with a high severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) load were more likely to show herpes simplex virus 1 detection (p = 0.037). Among patients coinfected with SARS-CoV-2 and HHVs, 26.4% showed central nervous system-associated neurological symptoms and herpetic manifestations. A statistically significant association was observed between neurological changes and HHV-6 detection (p = 0.034). Conclusions The findings showed a high prevalence of herpesvirus in patients with COVID-19. Furthermore, even though SARS-CoV-2 and HHV coinfection was not associated with poorer outcomes, the findings demonstrated the association between neurological symptoms and HHV-6 detection.
Read more »

Brain immune response to SARS-CoV-2 infectionBrain immune response to SARS-CoV-2 infectionIn a recently published article in the journal Current Opinion in Neurobiology, scientists at Washington University School of Medicine, St. Louis have described how immunological alterations associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may impact brain activities and induce acute and post-acute neurological symptoms in coronavirus disease 2019 (COVID-19) patients.
Read more »

Acute cardiac side effects after COVID-19 mRNA vaccination: a case series - European Journal of Medical ResearchAcute cardiac side effects after COVID-19 mRNA vaccination: a case series - European Journal of Medical ResearchBackground Vaccination against SARS-CoV-2 has been the main tool to contain the pandemic. The rush development of the 3 vaccines and their expedited approval have led to inoculation of millions of patients around the world, leading to a containment of the disease. Despite continuous viral mutations and the identification of weaker variants, the severity of the infections has been mild, with many patients being either asymptomatic or recovering at home. Currently the focus has shifted from the host of organ damage related to the infection to potential side effects of the vaccine. Myocarditis has been reported as one of the potential side effects from the mRNA vaccine, affecting young healthy individuals. Up to September 30, 2021, 1.243 cases of myocarditis after vaccination with BNT162b2 Comirnaty© were registered in young adults by the Paul-Ehrlich-Institute in Germany alone. The exact pathophysiology and the risk factors for myocarditis following vaccination remain unclear. We present a case series of eight patients with cardiac symptom shortly after SARS-CoV-2 mRNA vaccination (BNT162b6, Biontech, Comirnaty© or mRNA-1237 Moderna, Spikevax©). Patients and methods Eight patients between 13 and 56 years of age, vaccinated with either BNT162b2 or mRNA-1273 mRNA vaccine between January and August 2021 developed cardiac side effects shortly after either their first or second dose of the vaccine. Clinical data were retrieved from the clinical information system and analyzed. To support diagnosis of myocarditis or pericarditis, cardiac magnetic resonance imaging (MRI) was performed shortly after the onset of symptoms, with further investigations in severe cases. Symptoms were defined as dyspnea, chest pain and cardiac arrhythmia as determined by electrocardiography. Results Eight patients (5 males and 3 females) developed cardiac symptoms compatible with myocarditis, according to the CDC criteria, shortly after SARS-CoV-2 mRNA vaccination. Three patients (2 males, 1 femal
Read more »



Render Time: 2025-02-25 15:28:11